The issue of distributive justice has been an issue since the start of the vaccination campaign against the coronavirus. Now it is even more important: the shelf life of around 100 million vaccine doses will soon expire.
At the end of the year, the shelf life of more than 100 million corona vaccine doses worldwide will expire. If they are not redistributed urgently, the vaccine will be wasted, warned data analytics firm Airfinity.
More than 40 percent of these vaccine doses are in the EU, as Airfinity reported on Monday. If you consider that most recipient countries need a shelf life of at least two months from import in order to carry out the vaccination campaigns, 241 million vaccine doses threatened to expire unused.
If those vaccine doses were distributed promptly, that, along with the doses already purchased and made available, would be enough to vaccinate 70 percent of people in low- and middle-income countries against the coronavirus, Airfinity said. The British institute evaluates, among other things, company and scientific data.
The World Health Organization (WHO) in Geneva has been pushing for a fairer distribution of vaccines for months. The longer the virus circulates in countries with a low vaccination rate, the greater the risk of new variants against which the vaccines are less effective or not effective.
According to Airfinity, the EU countries as well as Japan, Canada, Great Britain and the USA will have a billion more vaccine doses available than they need by the end of the year, according to the analysis. These countries have pledged to donate 1.2 billion vaccine doses by the middle of next year. But only twelve percent of this was delivered.
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
